SEC Form 4 · accession 0001140361-15-032943
PLUS THERAPEUTICS, INC. · CNSY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steven Kesten
Officer — Exec VP and Chief MO
Period of report
Aug 19, 2015
Accepted (ET)
Aug 20, 2015 · 4:05 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001095981
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 19, 2015 | P | 6,000 | $0.3871 | A | 6,000 | I | By Family Trust |
| Common Stock | holding | — | — | — | 2,201 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Steven Kesten and Barbara Mary Kesten, trustees of The Kesten Living Trust Dated January 31, 2002.